Product
Supplier
Encyclopedia
Inquiry
Home > Chemicals Market Price & Insight > Ofloxacin Market Price & Analysis > Market Insights - Ofloxacin > Zhejiang Jingxin Pharmaceutical's levofloxacin API obtained European CEP certificate
— Share —

Zhejiang Jingxin Pharmaceutical's levofloxacin API obtained European CEP certificate

healthoo 2021-06-18
Recently, Shangyu Jingxin, a wholly-owned subsidiary of Jingxin Pharmaceuticals, received the European Pharmacopoeia Applicability Certificate (“CEP Certificate”) for Levofloxacin API issued by the European Drug Quality Administration (“EDQM”).

Please sign in to view all content or subscribe.

Comment
Comment

Trade Alert

Delivering the latest product trends and industry news straight to your inbox.
(We'll never share your email address with a third-party.)

Scan the QR Code to Share

Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.